THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Kenichi Tanaka to Thrombin

This is a "connection" page, showing publications Kenichi Tanaka has written about Thrombin.
Connection Strength

4.246
  1. Acute Traumatic Coagulopathy: Thrombin Is the Driver! Anesthesiology. 2017 09; 127(3):585.
    View in: PubMed
    Score: 0.559
  2. Reduced Requirement for Prothrombin Complex Concentrate for the Restoration of Thrombin Generation in Plasma From Liver Transplant Recipients. Anesth Analg. 2017 08; 125(2):609-615.
    View in: PubMed
    Score: 0.556
  3. Clinical and Practical Aspects of Restoring Thrombin Generation in Acute Coagulopathic Bleeding. Anesth Analg. 2017 02; 124(2):701.
    View in: PubMed
    Score: 0.537
  4. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg. 2009 May; 108(5):1433-46.
    View in: PubMed
    Score: 0.314
  5. In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry. Thromb Haemost. 2009 May; 101(5):827-33.
    View in: PubMed
    Score: 0.314
  6. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. Anesth Analg. 2008 Mar; 106(3):713-8, table of contents.
    View in: PubMed
    Score: 0.289
  7. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma. Anesth Analg. 2008 Mar; 106(3):719-24, table of contents.
    View in: PubMed
    Score: 0.289
  8. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin. Anesth Analg. 2007 Oct; 105(4):933-9, table of contents.
    View in: PubMed
    Score: 0.281
  9. The effects of argatroban on thrombin generation and hemostatic activation in vitro. Anesth Analg. 2004 Nov; 99(5):1283-1289.
    View in: PubMed
    Score: 0.230
  10. Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy. Anesth Analg. 2019 08; 129(2):339-345.
    View in: PubMed
    Score: 0.160
  11. Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass. Anesth Analg. 2016 Apr; 122(4):935-42.
    View in: PubMed
    Score: 0.127
  12. Computational simulation and comparison of prothrombin complex concentrate dosing schemes for warfarin reversal in cardiac surgery. J Anesth. 2016 06; 30(3):369-76.
    View in: PubMed
    Score: 0.125
  13. In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel. Thromb Res. 2013 Jul; 132(1):106-11.
    View in: PubMed
    Score: 0.104
  14. The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations. Anesth Analg. 2010 Sep; 111(3):601-8.
    View in: PubMed
    Score: 0.086
  15. Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VII. J Cardiothorac Vasc Anesth. 2010 Dec; 24(6):1026-7.
    View in: PubMed
    Score: 0.082
  16. Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII. Blood Coagul Fibrinolysis. 2008 Jan; 19(1):106-8.
    View in: PubMed
    Score: 0.071
  17. Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thromb Res. 2008; 122(1):117-23.
    View in: PubMed
    Score: 0.071
  18. Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro. Thromb Res. 2004; 113(5):333-9.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES